Trials / Withdrawn
WithdrawnNCT00247026
The Efficacy of Coenzyme Q10 And Curcumin in Patients With Myelodysplastic Syndromes
A Pilot Study to Determine the Clinical Efficacy of Coenzyme Q10 And Curcumin in Patients With Myelodysplastic Syndromes
- Status
- Withdrawn
- Phase
- Phase 1 / Phase 2
- Study type
- Interventional
- Enrollment
- 50 (planned)
- Sponsor
- Hadassah Medical Organization · Academic / Other
- Sex
- All
- Age
- 16 Years
- Healthy volunteers
- Not accepted
Summary
To determine the clinical effects of coenzyme Q10 and Curcumin in improving the cytopenias of patients with myelodysplastic syndromes. we propose to explore the efficacy of the natural compounds curcumin and CoQ10 in MDS because these two agents possess many of the effects that are desirable in MDS.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | curcumin; coenzyme q10 |
Timeline
- Start date
- 2007-04-01
- First posted
- 2005-11-01
- Last updated
- 2007-04-11
Locations
1 site across 1 country: Israel
Source: ClinicalTrials.gov record NCT00247026. Inclusion in this directory is not an endorsement.